Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000220720 | SCV000272378 | uncertain significance | not specified | 2020-01-08 | criteria provided, single submitter | clinical testing | The c.13329-11T>G variant in RYR2 has not been previously reported in individuals with cardiomyopathy, but has been identified in 5/98830 European chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is located in the 3' splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the c.13329-11T>G variant is uncertain. ACMG/AMP criteria applied: BP4. |
Color Diagnostics, |
RCV001187343 | SCV001354114 | likely benign | Cardiomyopathy | 2019-05-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002518192 | SCV002399360 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003997748 | SCV004821445 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000220720 | SCV005185493 | likely benign | not specified | 2024-05-06 | criteria provided, single submitter | clinical testing |